Logo
x

Search

Subscribe Now

viiv

PharmaShots Interview: Marc Meachem Shares Insight on the ViiV's 2021 Commitment to the Community

PharmaShots Interview: Marc Meachem Shares Insight on the ViiV's 2021 Commitment to the Community

  • April 7, 2021
Insights+: The US FDA New Drug Approvals in January 2021

Insights+: The US FDA New Drug Approvals in January 2021

  • February 18, 2021
PharmaShots Weekly Snapshots (Jan 18 - 22, 2021)

PharmaShots Weekly Snapshots (Jan 18 - 22, 2021)

  • January 22, 2021
PharmaShots Weekly Snapshot (November 16-20, 2020)

PharmaShots Weekly Snapshot (November 16-20, 2020)

  • November 20, 2020
ViiV Healthcare

    ViiV Healthcare's Vocabria in Combination with Rekambys Receives the NMPA’s Approval as an HIV-1 Injectable Treatment

    • October 26, 2023
    PharmaShots Weekly Snapshots (September 18–22, 2023)

      PharmaShots Weekly Snapshots (September 18–22, 2023)

      • September 22, 2023
      ViiV Healthcare’s Apretude (cabotegravir long-acting injectable and tablets) Receives EC’s Approval for HIV Prevention

        ViiV Healthcare’s Apretude (cabotegravir long-acting injectable and tablets) Receives EC’s Approval for HIV Prevention

        • September 19, 2023
        Insights+: EMA Marketing Authorization of New Drugs in July 2023

          Insights+: EMA Marketing Authorization of New Drugs in July 2023

          • August 24, 2023
          ViiV Healthcare Receives EMA’s CHMP Positive Opinion of Cabotegravir for HIV Prevention

            ViiV Healthcare Receives EMA’s CHMP Positive Opinion of Cabotegravir for HIV Prevention

            • July 24, 2023
            Dr. Harmony Garges, CMO at ViiV Healthcare, Shares Insights on Positive Findings from the SOLAR Study of Cabenuva

              Dr. Harmony Garges, CMO at ViiV Healthcare, Shares Insights on Positive Findings from the SOLAR Study of Cabenuva

              • May 18, 2023
              Image

              Incisive News in 3 Shots.

              Contact Us

              Our Information

              Follow Us

              Copyright © 2025 PharmaShots - All Rights Reserved.